NewslettersIntestinal Cell NewsUncategorizedBlockade of CHRNB2 Signaling with a Therapeutic Monoclonal Antibody Attenuates the Aggressiveness of Gastric Cancer CellsBy Justin.choi - August 3, 2021019Investigators generated gene knockouts through genome editing, performed RNA interference-mediated knockdown of gene expression, and ectopically expressed CHRNB2 in gastric cancer cells.[Oncogene] 7992332 {7992332:F9NPJWP8} apa 50 1 165240 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract